By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Innovative Medicines Initiative for Diabetes on Monday announced a €1 billion ($1.2 billion), 10-year project focusing on pancreatic islet cell function and survival.

The project will involve research into developing biomarkers and tools to better manage diabetes with the hope of curing the disease, which affects 285 million people worldwide, IMIDIA said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.